Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Start your free trial now

Instant access. No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: CRINONE

« Back to Dashboard
Crinone is a drug marketed by Actavis Labs Ut Inc and is included in one NDA. It is available from three suppliers.

The generic ingredient in CRINONE is progesterone. There are forty-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the progesterone profile page.

Summary for Tradename: CRINONE

Suppliers / Packagers: see list15

Pharmacology for Tradename: CRINONE

Drug ClassProgesterone

Clinical Trials for: CRINONE

Comparison of Crinone 8% Intravaginal Gel and IM Progesterone Supplementation for In Vitro Fertilization (IVF)
Status: Completed Condition: Infertility

A Study Using Micronised Progesterone (Crinone® 8%) in the Luteal Phase Support of Women Undergoing in Vitro Fertilisation (IVF) and Embryo Transfer (ET)
Status: Completed Condition: Infertility

Compare the Difference of P4 Concentration in Serum and Endometrium After Vaginal and IM P Administration
Status: Completed Condition: Postmenopausal Endometrium

Uterine Electrical Activity Before and After Progesterone Treatment for Preterm Labor
Status: Recruiting Condition: Preterm Labor

Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer
Status: Not yet recruiting Condition: Infertility

Sexual Absorption of Vaginal Progesterone
Status: Completed Condition: Infertility; Pregnancy

Comparing IM vs. Vaginal Progesterone for Pre-term Birth
Status: Completed Condition: Infant, Premature; Premature Birth

Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women
Status: Not yet recruiting Condition: Premature Birth

Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved (Frozen)-Thawed Day 3 Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone
Status: Recruiting Condition: Progesterone Supplementation

Progesterone and Brain Imaging Study
Status: Recruiting Condition: Nicotine Dependence; Nicotine Withdrawal

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc
GEL;VAGINAL020701-001Jul 31, 1997RXNo<disabled><disabled>
Actavis Labs Ut Inc
GEL;VAGINAL020701-002Jul 31, 1997RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn